摘要
目的通过临床观察评价神经妥乐平局部皮下注射治疗神经源性疼痛的疗效与安全性。方法21例神经源性疼痛患者皮下注射神经妥乐平3.6 U/次,1周2次,连续3周为1个疗程,采用疼痛视觉模拟评分法(VAS法)评定疗效并进行统计学分析。结果治疗后患者疼痛强度显著性降低(P<0.05),未出现明显不良反应。结论神经妥乐平皮下注射治疗神经源性疼痛,有效、安全、简便。
Objective To assess the management of neuropathic pain using neurotropin by subcutaneous injection.Methods 42 patients with neuropathic pain were randomly divided into two groups.The control group only administrated with routine treatments daily,and the trial group receiving neurotropnin at dosage of 3.6 U by subcutaneous injection twice every week,the course of treatment were both 3 weeks.The visual analogue scales VAS were measured before and after the treatment.Results The pain intensity was significantly decreased in the patients after the treatment without apparent adverse,P〈0.05.Conclusion The results suggest that it is effective,safe and convenient on the management of neuropathic pain using neurotropin by subcutaneous injection.
出处
《实用药物与临床》
CAS
2008年第2期75-76,共2页
Practical Pharmacy and Clinical Remedies
关键词
神经妥乐平
皮下注射
神经痛
Neurotropin
Subcutaneous injection
Neuropathic pain
